Key Metrics
1.9
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.63
5-Year SI
5-year SI
- N/A 2-year SI
- 0.72 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q3
Pharmacology
SJR
- Q3 Pharmacology
- Q3 Health Policy
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.77
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
3 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
29%
4 to 6 months
64%
7 to 9 months
0%
Above 9 months
7%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
DOAJ -
SJR
Topics Covered
- Nonsteroidal
- Competitive inhibitor
- Drug therapy problems
- Dyslipidemia
- Cross-sectional study
- Hand rub
- Drug Utilization
- Patient safety
- Levodopa
- Emergency department
- Healthcare settings
Journal Specifications
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2390 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2009 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 16 |
| Article Processing Charges | USD 2390 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
Planning to publish in Drug, Healthcare and Patient Safety ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
The Impact of Sacubitril/Valsartan on Heart Failure Patient with Reduced Left Ventricular Ejection Fraction: Single Center Retrospective Study in Saudi Arabia.
- 1 Sep 24
- Drug, healthcare and patient safety
-
Full paper
Adverse Events Following Immunization with Novel Oral Polio Vaccine Type 2, and the Experience and Challenges of Reporting in Sierra Leone [Letter
- 1 Sep 24
- Drug, healthcare and patient safety
-
Full paper
Medication-Related Hospital Admission Among Patients Admitted to the Emergency Ward at the University of Gondar, North West Ethiopia: A Cross Sectional Study.
- 1 Jul 24
- Drug, healthcare and patient safety
-
Full paper
Adverse Events Following Immunization with Novel Oral Polio Vaccine Type 2, and the Experience and Challenges of Reporting in Sierra Leone.
- 1 Jun 24
- Drug, healthcare and patient safety
-
Full paper
Therapeutic Potential of Treprostinil Inhalation Powder for Patients with Pulmonary Arterial Hypertension: Evidence to Date
- 1 Jun 24
- Drug, Healthcare and Patient Safety
-
Full paper
Rapid Onset and Recovery Linezolid-Induced Thrombocytopenia: A Large-Sample, Single-Center Retrospective Cohort Study
- 1 May 24
- Drug, Healthcare and Patient Safety
Scite analysis
Powered by scite_
290 articles received 4.1k citations see all
- 229 Supporting
- 3,580 Mentioning
- 88 Contrasting
Editorial notices
- 2 Retractions
- 0 Withdrawals
- 0 Corrections
- 1 Errata
- 0 Expression of Concern
FAQs
How long has Drug, Healthcare and Patient Safety been actively publishing?
Drug, Healthcare and Patient Safety has been in operation since 2009 till date.
What is the publishing frequency of Drug, Healthcare and Patient Safety ?
Drug, Healthcare and Patient Safety published with a Continuous publication frequency.
How many articles did Drug, Healthcare and Patient Safety publish last years ?
In 2023, Drug, Healthcare and Patient Safety published 16 articles.
What is the eISSN & pISSN for Drug, Healthcare and Patient Safety ?
For Drug, Healthcare and Patient Safety,eISSN is 1179-1365 and pISSN is1179-1365.
What is Citescore for Drug, Healthcare and Patient Safety ?
Citescore for Drug, Healthcare and Patient Safety is 1.9.
What is SNIP score for Drug, Healthcare and Patient Safety ?
SNIP score for Drug, Healthcare and Patient Safety is 0.77.
What is the SJR for Drug, Healthcare and Patient Safety ?
SJR for Drug, Healthcare and Patient Safety is Q3.
Who is the publisher of Drug, Healthcare and Patient Safety ?
DOVE MEDICAL PRESS LTD is the publisher of Drug, Healthcare and Patient Safety.